Edition:
United Kingdom

Kalvista Pharmaceuticals Inc (KALV.OQ)

KALV.OQ on NASDAQ Stock Exchange Global Market

15.59USD
23 Aug 2019
Change (% chg)

$-0.32 (-2.01%)
Prev Close
$15.91
Open
$15.75
Day's High
$16.02
Day's Low
$15.44
Volume
32,280
Avg. Vol
51,375
52-wk High
$34.65
52-wk Low
$14.61

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Thomas Crockett

43 2016 Chief Executive Officer, Director

Benjamin Palleiko

52 2019 Chief Financial Officer, Chief Business Officer

Andreas Maetzel

54 2017 Senior Vice President, Medical

Edward Feener

57 2016 Chief Scientific Officer

Christopher Yea

55 2016 Chief Development Officer